Finally, vegetal extracts rich in ABA have been already used in clinical studies and have shown beneficial effects on glycemia and lipidemia in borderline or prediabetic subjects [10,13,14,25], indicating that nutraceutical products containing ABA at the dose used in this study could provide an immediately available source of the hormone for adjuvant therapy in addition to insulin in T1D patients. The gene discussed is INS; the disease is hyperlipidemia.